A nanomolar multivalent ligand as entry inhibitor of the hemagglutinin of avian influenza.
暂无分享,去创建一个
Moritz Waldmann | Bernd Meyer | B. Meyer | D. Rehders | M. Waldmann | Dirk Rehders | Raffael Jirmann | Ken Hoelscher | Martin Wienke | Felix C. Niemeyer | M. Wienke | Raffael Jirmann | Felix C Niemeyer | Ken Hoelscher
[1] Xiangqun Zeng,et al. Engineering peptide linkers for scFv immunosensors. , 2008, Analytical chemistry.
[2] David J. Stevens,et al. Haemagglutinin mutations responsible for the binding of H5N1 influenza A viruses to human-type receptors , 2006, Nature.
[3] G. Air,et al. Structure of influenza virus neuraminidase B/Lee/40 complexed with sialic acid and a dehydro analog at 1.8-A resolution: implications for the catalytic mechanism. , 1994, Biochemistry.
[4] H. Klenk,et al. Neuraminidase Is Important for the Initiation of Influenza Virus Infection in Human Airway Epithelium , 2004, Journal of Virology.
[5] I D Kuntz,et al. Inhibition of the fusion-inducing conformational change of influenza hemagglutinin by benzoquinones and hydroquinones. , 1993, Biochemistry.
[6] A. Gamian,et al. Inhibition of influenza A virus hemagglutinin and induction of interferon by synthetic sialylated glycoconjugates. , 1991, Canadian journal of microbiology.
[7] Ian A. Wilson,et al. Structure and Receptor Specificity of the Hemagglutinin from an H5N1 Influenza Virus , 2006, Science.
[8] H. Yen,et al. Targeting the host or the virus: Current and novel concepts for antiviral approaches against influenza virus infection , 2012, Antiviral Research.
[9] Hideo Goto,et al. Avian flu: Isolation of drug-resistant H5N1 virus , 2005, Nature.
[10] Y. Cheng,et al. Relationship between the inhibition constant (K1) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reaction. , 1973, Biochemical pharmacology.
[11] Jason E Gestwicki,et al. Influencing receptor-ligand binding mechanisms with multivalent ligand architecture. , 2002, Journal of the American Chemical Society.
[12] J. Knowles,et al. Design and evaluation of a tightly binding fluorescent ligand for influenza A hemagglutinin , 1992 .
[13] Thomas Peters,et al. NMR spectroscopy techniques for screening and identifying ligand binding to protein receptors. , 2003, Angewandte Chemie.
[14] J. Skehel,et al. X-ray structures of H5 avian and H9 swine influenza virus hemagglutinins bound to avian and human receptor analogs , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[15] P. Kitov,et al. On the nature of the multivalency effect: a thermodynamic model. , 2003, Journal of the American Chemical Society.
[16] P. Lutz,et al. Synthese anomerer Sialinsäure‐methylketoside , 1966 .
[17] G. Whitesides,et al. Polyacrylamides Bearing Pendant α-Sialoside Groups Strongly Inhibit Agglutination of Erythrocytes by Influenza Virus: The Strong Inhibition Reflects Enhanced Binding through Cooperative Polyvalent Interactions , 1996 .
[18] R. Webster,et al. The Influenza Virus Enigma , 2009, Cell.
[19] C. Boucher,et al. Emergence of a multidrug-resistant pandemic influenza A (H1N1) virus. , 2010, The New England journal of medicine.
[20] R. Webster,et al. Are We Ready for Pandemic Influenza? , 2003, Science.
[21] Wei Zhang,et al. Discovery of the first series of small molecule H5N1 entry inhibitors. , 2009, Journal of medicinal chemistry.
[22] Hua Yang,et al. Structures of Receptor Complexes of a North American H7N2 Influenza Hemagglutinin with a Loop Deletion in the Receptor Binding Site , 2010, PLoS pathogens.
[23] Mark von Itzstein,et al. The war against influenza: discovery and development of sialidase inhibitors , 2007, Nature Reviews Drug Discovery.
[24] David J Stevens,et al. Structure of influenza hemagglutinin in complex with an inhibitor of membrane fusion , 2008, Proceedings of the National Academy of Sciences.
[25] G M Whitesides,et al. A trivalent system from vancomycin.D-ala-D-Ala with higher affinity than avidin.biotin. , 1998, Science.
[26] I. Wilson,et al. Structure of the haemagglutinin membrane glycoprotein of influenza virus at 3 Å resolution , 1981, Nature.
[27] George M Whitesides,et al. Polyvalent Interactions in Biological Systems: Implications for Design and Use of Multivalent Ligands and Inhibitors. , 1998, Angewandte Chemie.
[28] Shuwen Liu,et al. Influenza A Virus Entry Inhibitors Targeting the Hemagglutinin , 2013, Viruses.
[29] T. Sakai,et al. Roles of neuraminidase in the initial stage of influenza virus infection. , 2006, Microbes and infection.
[30] H. Ogura,et al. Studies on sialic acids. V: Synthesis of α- and β-D-Neu5Acp-(2→6)-lactose , 1986 .
[31] J. Knowles,et al. Molecular recognition of bivalent sialosides by influenza virus , 1991 .
[32] G M Whitesides,et al. Hemagglutinins from two influenza virus variants bind to sialic acid derivatives with millimolar dissociation constants: a 500-MHz proton nuclear magnetic resonance study. , 1989, Biochemistry.
[33] Bernd Meyer,et al. Characterization of Ligand Binding by Saturation Transfer Difference NMR Spectroscopy. , 1999, Angewandte Chemie.
[34] R. Read,et al. Shiga-like toxins are neutralized by tailored multivalent carbohydrate ligands , 2000, Nature.
[35] J. Knowles,et al. Monovalent sialosides that bind tightly to influenza A virus. , 1991, Journal of medicinal chemistry.